Cooper Companies (The) has grown revenue 7.3% a year over three years and 9.7% a year over five, with earnings per share compounding at −1.2%. Revenue growth, 3-year annual rate: +7.3% (Medical Instruments & Supplies median +10%). Revenue growth, 5-year rate: +9.7%, growth has slowed since the five-year average. Earnings per share, 3-year rate: −1.2%, earnings lagged revenue: the growth is costing something. Years of annual history on file: 18, FY2008 to FY2025, as filed.

COOCooper Companies (The)

HealthcareUSD

$72.67

$58.9852 weeks$84.32

Is it growing?

Is COO growing?

Cooper Companies (The) has grown revenue 7.3% a year over three years and 9.7% a year over five, with earnings per share compounding at −1.2%.

+7.3%

Revenue growth, 3-year annual rate · Medical Instruments & Supplies median +10% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +9.7%
Revenue growth, 5-year rate · +7.3% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: −1.2%
Earnings per share, 3-year rate · revenue +7.3% · earnings lagged revenue: the growth is costing something
Years of annual history on file: 18
Years of annual history on file · FY2008 to FY2025, as filed